[1]
“DRUG DOSAGE REGIMEN FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN STEM CELL TRANSPLANTATION: A REVIEW”, JRA, vol. 7, no. 2, pp. 210–222, Dec. 2025, Accessed: Apr. 29, 2026. [Online]. Available: https://journlra.org/index.php/jra/article/view/2073